1,381
Views
0
CrossRef citations to date
0
Altmetric
Original research

Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer

, , , , , , , , , , & show all
Article: 2275846 | Received 03 May 2023, Accepted 22 Oct 2023, Published online: 13 Nov 2023